---
gate: human-aging-halted
last_updated: "2026-06-18T00:00:00.000Z"
---

### P10 scenario (2037): Age-freezing therapy approved within ~11 years

**Retirement planning:** If aging can be halted by 2037, the concept of retirement at 65-70 becomes obsolete. Tamir (late 30s/early 40s) would potentially have centuries of productive life ahead. Implication: reduce the urgency of a hard retirement deadline; instead, prioritize skills, relationships, and health that compound over very long horizons. Hedge against this NOT happening — do not orient your whole life around the longevity case.

**Healthcare costs:** Early-adopter access to geroprotective therapies may be expensive ($50K-$200K/year initially, based on current biologic drug pricing). Building a dedicated healthcare/longevity savings fund of $500K-$1M by the mid-2030s would put the family in reach of early access. Israeli universal healthcare may or may not cover experimental longevity therapies initially, so the personal fund is the more reliable path.

**Family planning:** Kids (currently ~8-12) would grow up in a world where their parents might not age. This creates novel family dynamics: the multi-generational model of how a family hands things down changes fundamentally. Start discussing longevity planning with the older children as they enter adulthood.

### P50 scenario (2048): Age-freezing therapy approved within ~22 years

**Career planning:** Tamir would be in his early 60s. Traditional life-stage planning remains relevant but should build in optionality: if the therapy arrives at 60, he may want to "un-retire" and start new ventures with a biologically 30-year-old body. Maintain career optionality and network depth rather than planning for a hard stop.

**Healthcare costs:** Invest steadily in preventive health now — the goal is to be healthy enough at 60 to benefit from geroprotective therapies when they arrive. Exercise, sleep, metabolic health, and cancer screening matter more than any supplement. Bryan Johnson's $2M/year Protocol is unnecessary; the top interventions (exercise, sleep, nutrition, social connection) are nearly free.

**Insurance:** Long-term life insurance bought now becomes a meaningful hedge if aging halts. Consider locking in long-term life insurance while in good health and at current life-stage rates.

**Family:** Children would be in their 30s-40s when therapies arrive. They are likely to be direct beneficiaries. Encourage them to pursue careers in longevity science, AI, or adjacent fields — both for impact and for early access to cutting-edge therapies.

### P90 scenario (2072): Age-freezing therapy approved within ~46 years

**Retirement planning:** Conventional life-stage planning applies. Tamir would be in his late 80s. The primary question becomes: will he be healthy enough to benefit? Aggressive preventive health and healthspan optimization (not lifespan extension) is the rational strategy.

**Healthcare costs:** Standard Israeli healthcare plus supplemental insurance. Focus spending on quality-of-life interventions (joint replacements, cognitive health, cardiovascular prevention) rather than speculative longevity therapies.

**Family:** Grandchildren or great-grandchildren would be the primary beneficiaries. Legacy planning should account for the possibility that descendants live far longer than historical norms — long-horizon family and charitable structures become relevant.

**Key hedging strategy across all scenarios:** The asymmetry favors investing in personal health NOW. Exercise, sleep, metabolic optimization, and cancer screening are high-value regardless of which scenario materializes. The worst outcome is dying of a preventable cause at 75 when age-reversing therapy becomes available at 76. The marginal dollar spent on personal health today has higher expected value than almost anything else you could do with it on this gate.